USE OF TDGF1 GENE IN PREPARATION OF DRUGS FOR TREATING AGING-RELATED DISEASES OR REVERSING CELL AGING
Publication
EP2024078124A1
Kind: A1
Mar 18, 2026
Applicants
Allife Regenerative Medicine Tech. Beijing Co. Ltd
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
C07K 14/475 20060101AFI20251112BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR